The results demonstrated that among these factors, TRAF3 remained an independent predictor of a favorable prognosis in glioma, with elevated TRAF3 expression consistently correlating with improved survival outcomes, regardless of other clinical and genetic variables (Supplemental Figure 1C). Here, TRAF3 is linked to central nervous system cancer.